title: Metabotropic glutamate receptor 5 negative modulation in phase I clinical trial: potential impact of circadian rhythm on the neuropsychiatric adverse reactions-do hallucinations matter?
abstract: Metabotropic Glutamate Receptor 5 (mGluR5) negative allosteric modulators (NAMs) may play a role in some psychiatric disorders such as anxiety and depression. The pharmacokinetic profile and pharmacodynamics effects of mGluR5-NAMs have been previously reported. We performed a post hoc analysis of pharmacological and clinical data obtained from 18 young healthy female subjects who received a mGluR5-NAM in the context of a phase I drug-drug interaction study between a mGluR5 NAM and a monophasic oral contraceptive. mGluR5-NAM was administered in an escalating bidaily dose level design. There was no interaction between the OC and mGluR5-NAM. Higher morning mGluR5-NAM plasma concentrations were found compared to evening concentrations. Most of the observed clinically significant neuropsychiatric adverse reactions occurred nocturnally and included visual (pseudo) hallucinations, insomnia accompanied by secondary behavioural disorders, and cognitive dysfunction symptoms of sufficient severity to interfere with daily functioning. Circadian rhythm-related physiological variations in drug absorption and disposition may explain this pharmacokinetics-pharmacodynamics apparently disproportionate relationship. We suggest that clinical trials evaluating basic pharmacokinetic properties of psychiatric medications consider potential drug's chronopharmacokinetics. This may assist with dose optimization and minimize serious neuropsychiatric adverse reactions in the vulnerable psychiatric patient.
authors.affiliation: Rob Giel Research Centre, Department of Psychiatry, University Medical Centre Groningen (UMCG), Hanzeplein 1, 9713 GZ Groningen, The Netherlands.
authors.forename: Khalid
authors.identifier: 0000-0003-0340-4644
authors.initials: K
authors.lastname: Abou Farha
authors.affiliation: Rob Giel Research Centre, Department of Psychiatry, University Medical Centre Groningen (UMCG), Hanzeplein 1, 9713 GZ Groningen, The Netherlands.
authors.forename: Richard
authors.initials: R
authors.lastname: Bruggeman
authors.affiliation: Department of Epidemiology (Medical Statistics), University Medical Centre Groningen (UMCG), Hanzeplein 1, 9713 GZ Groningen, The Netherlands.
authors.forename: Corine
authors.initials: C
authors.lastname: Baljé-Volkers
references.citation: Drug Metab Dispos. 2009 Jan;37(1):106-15
references.pmid: 18838502
references.citation: PLoS One. 2009 Aug 25;4(8):e6755
references.pmid: 19707548
references.citation: Integr Comp Biol. 2005 Aug;45(4):658-64
references.pmid: 21676814
references.citation: Molecules. 2011 Mar 02;16(3):2097-106
references.pmid: 21368721
references.citation: Neuropharmacology. 2011 Jan;60(1):66-81
references.pmid: 20637216
references.citation: Neuropharmacology. 2003 Apr;44(5):562-72
references.pmid: 12668042
references.citation: Clin Chem. 1986 May;32(5):801-4
references.pmid: 3698272
references.citation: J Res Pharm Pract. 2012 Jul;1(1):3-9
references.pmid: 24991580
references.citation: J Biomed Sci. 2011 Feb 22;18:19
references.pmid: 21342491
references.citation: Seizure. 2012 Oct;21(8):658-60
references.pmid: 22832396
references.citation: J Cereb Blood Flow Metab. 2001 May;21(5):608-12
references.pmid: 11333371
references.citation: Adv Drug Deliv Rev. 2010 Jul 31;62(9-10):904-17
references.pmid: 20542067
references.citation: Front Pharmacol. 2012 May 07;3:84
references.pmid: 22586398
references.citation: J Neurol Neurosurg Psychiatry. 2001 Jun;70(6):727-33
references.pmid: 11385004
references.citation: Epilepsia. 2011 Mar;52(3):562-71
references.pmid: 21294720
references.citation: Br J Clin Pharmacol. 1991 Nov;32(5):627-9
references.pmid: 1954078
references.citation: J Circadian Rhythms. 2005 Mar 10;3(1):3
references.pmid: 15760472
references.citation: Psychopharmacology (Berl). 2004 Sep;175(3):310-8
references.pmid: 15024550
references.citation: J Neurosci. 2007 Dec 26;27(52):14326-37
references.pmid: 18160640
references.citation: Front Cell Neurosci. 2012 Jan 30;6:4
references.pmid: 22319473
references.citation: J Psychiatry Neurosci. 2002 Nov;27(6):406-15
references.pmid: 12491573
references.citation: Brain. 1998 Oct;121 ( Pt 10):1819-40
references.pmid: 9798740
references.citation: Trends Pharmacol Sci. 2011 Dec;32(12):708-14
references.pmid: 21975165
references.citation: J Clin Endocrinol Metab. 2001 Aug;86(8):3787-94
references.pmid: 11502812